International Waldenstrom’s Macroglobulinemia Foundation

Language

International Waldenstrom’s Macroglobulinemia Foundation

Language

Vision & Mission

With the IWMF You Are Never Alone

The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a patient-founded and patient-driven, nonprofit organization that is dedicated to a simple but compelling vision and mission.

Our Vision

A World without Waldenstrom’s macroglobulinemia (WM).

Our Mission

Support and educate everyone affected by Waldenstrom’s macroglobulinemia (WM) to improve patient outcomes while advancing the search for a cure.

Our Values

Behavior

  • Community – We believe in engaging the WM community by sharing information, providing support, and working together to eradicate the disease.
  • Teamwork – We work as a team that includes all WM stakeholders.
  • Integrity – We care about the WM community and commit to the highest financial and ethical standards, with transparency in all that we do.

Execution

  • Focus – We are fiercely dedicated to providing support and education for those affected by WM and supporting research to improve and extend lives and find a cure for the disease.
  • Collaboration – We leverage the collective passion and genius of other blood cancer organizations and the medical and research communities.
  • Accountability – We are transparent and accountable at every level to the WM community and the general public.

Our Compelling Intentions

  1. Assume leadership to significantly increase the number, scope and coordination of global WM research projects.
  2. Become the global thought leader and authoritative source of information and resources in WM.
  3. Ensure every doctor and nurse worldwide who works in blood cancer knows about the IWMF and the resources we offer.
  4. Ensure every person diagnosed worldwide with WM knows about the IWMF and the resources we offer.
  5. Expand worldwide awareness of WM and the IWMF.
  6. Significantly increase and diversify our sources of funding to support our mission.